相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Transforming Growth Factor-β as a Therapeutic Target in Hepatocellular Carcinoma
Gianluigi Giannelli et al.
CANCER RESEARCH (2014)
Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma
Hsin-Jung Lee et al.
CARCINOGENESIS (2014)
TGF-β signal shifting between tumor suppression and fibro-carcinogenesis in human chronic liver diseases
Koichi Matsuzaki et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
B-crystallin complexes with 14-3-3 to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma
Xiao-Yong Huang et al.
HEPATOLOGY (2013)
Biology of the TAM Receptors
Greg Lemke
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Role of Smads in TGF beta signaling
Carl-Henrik Heldin et al.
CELL AND TISSUE RESEARCH (2012)
Phospho-specific Smad3 signaling Impact on breast oncogenesis
Elizabeth Tarasewicz et al.
CELL CYCLE (2012)
Axl-dependent signalling: a clinical update
Vyacheslav A. Korshunov
CLINICAL SCIENCE (2012)
TGF-β in Epithelial to Mesenchymal Transition and Metastasis of Liver Carcinoma
Patrick Reichl et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy
Seok-Hyung Kim et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2012)
Identification of Axl as a downstream effector of TGF-β1 during Langerhans cell differentiation and epidermal homeostasis
Thomas Bauer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Silencing of 14-3-3ζ over-expression in hepatocellular carcinoma inhibits tumor growth and enhances chemosensitivity to cis-diammined dichloridoplatium
Jung Eun Choi et al.
CANCER LETTERS (2011)
Smad phosphoisoform signaling specificity: the right place at the right time
Koichi Matsuzaki
CARCINOGENESIS (2011)
A Human Model of Epithelial to Mesenchymal Transition to Monitor Drug Efficacy in Hepatocellular Carcinoma Progression
Franziska van Zijl et al.
MOLECULAR CANCER THERAPEUTICS (2011)
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
M. Z. Xu et al.
ONCOGENE (2011)
Post-translational modification of 14-3-3 isoforms and regulation of cellular function
Alastair Aitken
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2011)
Structural basis of 14-3-3 protein functions
Tomas Obsil et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2011)
Nuclear beta-Catenin Induces an Early Liver Progenitor Phenotype in Hepatocellular Carcinoma and Promotes Tumor Recurrence
Gudrun Zulehner et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
14-3-3 sigma and 14-3-3 zeta plays an opposite role in cell growth inhibition mediated by transforming growth factor-beta 1
Hye-Young Hong et al.
MOLECULES AND CELLS (2010)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Modulation of TGF-beta signaling during progression of chronic liver diseases
Koichi Matsuzaki
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
AXL is a potential target for therapeutic intervention in breast cancer progression
Yi-Xiang Zhang et al.
CANCER RESEARCH (2008)
Immunobiology of the TAM receptors
Greg Lemke et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Involvement of EGF receptor and c-Src in the survival signals induced by TGF-β1 in hepatocytes
MM Murillo et al.
ONCOGENE (2005)
TGF-β and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions
S Mori et al.
ONCOGENE (2004)